ANI Pharmaceuticals (NASDAQ:ANIP - Get Free Report) was upgraded by equities research analysts at StockNews.com from a "sell" rating to a "hold" rating in a note issued to investors on Wednesday. A number of other research analysts have also recently issued reports on the stock. Jefferies Financial Group initiated coverage on shares of ANI Pharmaceuticals [...]